Deerfield Management Company, L.P. (Series C) Medpace Holdings, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 736 shares of MEDP stock, worth $400,685. This represents 0.01% of its overall portfolio holdings.
Number of Shares
736Holding current value
$400,685% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MEDP
# of Institutions
669Shares Held
26.9MCall Options Held
53.6KPut Options Held
108K-
Black Rock Inc. New York, NY2.58MShares$1.4 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.39MShares$1.3 Billion0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT946KShares$515 Million1.61% of portfolio
-
Mawer Investment Management Ltd. Calgary, A0817KShares$445 Million1.35% of portfolio
-
State Street Corp Boston, MA707KShares$385 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $16.9B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...